Aktuell Lesenswertes - Deutsche Autoimmun-Stiftung
Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes | Nature Immunology
Abatacept Treatment Does Not Preserve Renal Function in the Streptozocin-Induced Model of Diabetic Nephropathy | PLOS ONE
Risk of Diabetes Treatment Switching or Intensification Associated with Use of Abatacept versus Other Biologic Drugs in Patients with Rheumatoid Arthritis and Diabetes Mellitus - ACR Meeting Abstracts
Abatacept decreases TFH cells during an ongoing autoimmune response in... | Download Scientific Diagram
How ORENCIA® Works | ORENCIA® (abatacept)
News
New Frontiers in the Treatment of Type 1 Diabetes - ScienceDirect
Inhibition of T-cell activation by the CTLA4-Fc Abatacept is sufficient to ameliorate proteinuric kidney disease | American Journal of Physiology-Renal Physiology
Arthritis drug abatacept slows type 1 diabetes progression - Diabetes
A machine learning approach to predict response to immunotherapy in type 1 diabetes | Cellular & Molecular Immunology
CTLA4-Ig (abatacept): a promising investigational drug for use in type 1 diabetes
Artikel Deutsches Ärzteblatt
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial - The Lancet
ABATACEPT-Studie: - Diabetes schon im Vorläuferstadium stoppen?
Drug Insight: abatacept for the treatment of rheumatoid arthritis | Nature Reviews Rheumatology
Effect of abatacept treatment on the development of albuminuria and... | Download Scientific Diagram
ABATACEPT-Studie - Diabetiker.Info
Abatacept Prevention Study | TRIALNET Type 1 Diabetes TrialNet
Typ 1 Diabetes im Vorstadium stoppen? ABATACEPT-Studie
JCI Insight - B lymphocyte alterations accompany abatacept resistance in new-onset type 1 diabetes
Uncovering Pathways to Personalized Therapies in Type 1 Diabetes
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial - The Lancet
